Good day for Biotech in early-middle trial progress ? (sinister cackle heard in background).
EMS/EMSOB - Phase-IIa trial for anti-malarial treatment particularly for children, has announced good results.
I like their attention to future trials and expression of a plan for eventual commercialisation.
Today however may not be a good day for this sort of thing, but worth watching.
Dicscl: I don't hold.
- Forums
- ASX - Day Trading
- daytrades april 28 pre-market
daytrades april 28 pre-market, page-20
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)